Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations-Reference-Cited by-同舟云学术

Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

Published:2014-09-12 Issue:11 Volume:57 Page:2237-2250
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Patorno Elisabetta,Patrick Amanda R.,Garry Elizabeth M.,Schneeweiss Sebastian,Gillet Victoria G.,Bartels Dorothee B.,Masso-Gonzalez Elvira,Seeger John D.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-014-3364-z.pdf

Reference132 articles.

1. Arana A, Rivero E, Egberts TCG (2004) What do we show and who does so? An analysis of the abstracts presented at the 19th ICPE. Pharmacoepidemiol Drug Saf 13:S330–S331

2. Schneeweiss S, Avorn J (2005) A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58:323–337

3. Schneeweiss S (2010) A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf 19:858–868

4. Suissa S (2008) Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 167:492–499

5. Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA (2005) Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 28:2345–2351

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment modification patterns of glucose-lowering agents in Saudi Arabia: A retrospective real-world data analysis;Diabetes Research and Clinical Practice;2024-08

2. Ibuprofen, other NSAIDs and COVID-19: a narrative review;Inflammopharmacology;2023-08-21

3. Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark;Diabetes Therapy;2022-10-31

4. Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions;Nature Communications;2022-08-31

5. Time‐related biases in perinatal pharmacoepidemiology: A systematic review of observational studies;Pharmacoepidemiology and Drug Safety;2022-07-24